Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses.

Trial Profile

Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses.

Suspended
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2012

At a glance

  • Drugs BIBX 1382 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jul 2012 Additional trial location (USA) added as reported by ClinicalTrials.gov.
    • 10 Jul 2012 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
    • 23 Jul 2008 Planned patient number is now 80 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top